First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
2016 ◽
Vol 17
(7)
◽
pp. 928-942
◽
Keyword(s):
2015 ◽
Vol 16
(13)
◽
pp. 1370-1379
◽
2020 ◽
Vol 21
(9)
◽
pp. 1188-1200
◽
Keyword(s):